Clinical trial NCT05763355: Multicentric Comparative Prospective Study of the Benefits and Risks of Biopsy Prostate Using Transrectal or Transperineal Procedure for the Prostate Cancer Diagnostic
Official title: Multicentric Comparative Prospective Study of the Benefits and Risks of Biopsy Prostate Using Transrectal or Transperineal Procedure for the Prostate Cancer Diagnostic.
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Patients With Suspected Prostate Cancer
Keywords: Transpérinéal
Transrectal
Biopsy
Prostate
Cancer
Lead sponsor: Elsan
Sponsor class: OTHER
First posted: 2023-03-10
Enrollment: 596
Sex: MALE
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: DIAGNOSTIC

Brief summary: The performance of prostatic biopsies is an essential element to confirm the diagnosis of prostate cancer and to specify the characteristics of the tumor in terms of stage and grade.

The first route of prostatic biopsies is mainly transrectal with passage of a needle introduced into the guide fixed on the endorectal ultrasound probe. There is another possible access route, transperineal, with prostatic puncture by a needle introduced transcutaneously, guided by an endorectal ultrasound image. The first transperineal route would offer the first benefit for the patient, to reduce the infectious risk inherent in the endorectal way. It would also reduce the risk of rectal bleeding.

In addition, the transperineal pathway appears to be able to improve the detection threshold of prostatic tumours located on the anterior part of the gland due to the angle of penetration of the needle and its more anterior positioning relative to the prostate.

There is currently no randomized comparison study of the transperineal versus transrectal procedure on infectious risk. The aim of the project is to enable this comparative study, within our institution where experienced urologist surgeons practice.


Eligibility criteria: Inclusion Criteria:

* Patients with suspected prostate cancer with at least one of the following criteria met :

  1. MRI Staging: T2 or T3a,
  2. MRI Grading: Pirads greater than or equal to 3
  3. MRI tumor volume greater than or equal to 0.5 cm3

  e.Patient without tumor lesion detected by prostate MRI less than 3 months old with PSA \> 4 ng/ml, or an observed suspicious induration to the rectal exam
* Voluntarily signed and dated written informed consents prior to any study specific procedure,

Exclusion Criteria:

* Other medical conditions may interfere with the conduct of the study and, in the judgment of the investigator, would make the patient inappropriate for entry into this study,
* Individuals deprived of liberty or placed under legal guardianship,
* Unwillingness or inability to comply with the study protocol for any reason.
* Patients without a health insurance

Primary outcomes:
measure: Comparison of the rate of occurrence of biopsy-induced infection in both groups
timeFrame: 30 days after intervention
Secondary outcomes:
measure: Comparison of the rate of rectal bleeding in both groups
timeFrame: 30 days after intervention
measure: Comparison of the rate of urethral bleeding (hematuria and urethrorrhagia) in both groups
timeFrame: 30 days after intervention
measure: Comparison of the percentage of negative biopsies in both groups
timeFrame: 30 days after intervention
measure: Comparison of the percentage of positive biopsies on on anterior areas in both groups
timeFrame: 30 days after intervention
measure: Comparison of the Percentage of underestimation of the stage of tumor development in both groups
timeFrame: 3 months after intervention
measure: Assess the pain (tolerance) felt by the patient according to the biopsy method used
timeFrame: 1 day
measure: Comparison of the Room occupancy time in both groups
timeFrame: 1 day
measure: Comparison of the Procedure Time in both groups
timeFrame: 1 day
measure: Comparison of the Average Length of Stay in both groups
timeFrame: 1 day
Other outcomes:
Locations:
city: Bordeaux
country: France
facility: Clinique St Augustin
city: Brive-la-Gaillarde
country: France
facility: Centre Médico-Chirurgical Les Cèdres
Study officials:
References: